International SOS is assisting clients in West Africa during the current Ebola outbreak.
Medical personnel are working closely with around 100 client organisations with staff and/or operations in the affected region. Cases have been confirmed or are under investigation in Guinea, Liberia and Sierra Leone.
International SOS routinely has physicians working on client sites in a number of locations close to where cases have been confirmed.
Staff from Assistance Centres in London and Paris have been contacting organisations to discuss their concerns and the preventative measures they can put in place.
Andre Willemse, International SOS Regional Medical Director for Guinea, Liberia and Sierra Leone said:
“There is a huge amount of uncertainty at the moment surrounding this outbreak and new information is reaching us on an hourly basis. A key priority for us is to protect our medical staff as they find themselves in the frontline facing this lethal virus. We also need to be ready to safely manage patients who may have the disease.
We are working hard to share information sensibly, as it becomes available, with our clients. This will assist organisations who aim to try and mitigate risks for staff and their families. We are offering advice on how our clients’ business operations can continue in the affected areas as much as possible.”
This is the first time Ebola has been confirmed in Guinea, with early cases suspected to have appeared in February. Ebola is a rare, serious viral disease that infects humans and other primates. It may be transmitted to humans when they eat meat or have other contact with infected animals. Infected people can spread the disease to others, as the virus is present in body fluids such as blood, saliva, and urine.
The disease incubates for 2-21 days before symptoms develop suddenly. Early symptoms of Ebola include fever, headache, muscle pain and weakness. Other symptoms may involve a rash, nausea and vomiting, abdominal pain and diarrhoea. Bleeding occurs in some cases which can lead to shock, massive haemorrhage and death. There is no vaccination against Ebola and no cure for the disease.
Early indications are that it is highly likely that the Zaire strain is responsible for the outbreak. This strain is associated with a fatality rate of up to 90%.
International SOS will hold a webinar on Wednesday, 26 March to discuss the latest developments and is distributing an advisory ‘toolkit’ to help clients educate individual members on the dangers of the virus.
Detailed information is being made available and will include the following:
• Defer non-essential travel to Guinea until further information is available and the situation is clarified
• Defer non-essential travel to affected areas of Lofa county in Liberia until further information is available and the situation is clarified
For those who are in Guinea and Liberia:
• Do not visit the affected areas
• Pay strict attention to hygiene
• Avoid hospitals
• Avoid funerals
• Avoid contact with sick people and their bodily fluids
Those considered to be high risk are:
• Healthcare workers
• Family or others caring for sick people
• Family or others managing the bodies of those who have died
• Those attending funerals (as there is often a requirement to wash the body)
Business travellers and expatriates, not involved in these activities, are classed as low risk.
Members are encouraged to contact one of the 27 International SOS Assistance Centres for advice before, during or after travel to any of the affected countries.
Source: International SOS
Publishing or copying the content of AVIATION Times without a written electronic permission is strictly forbidden. If you have any information, tips, videos, photos or your press releases for us contact us at news@aviation-times.aero.
AVIATION TIMES © Copyright 2012 - 2025
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.